阿库斯生物科学 RCUS
$18.28 +$0.59 (+3.34%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $18.28 0.00%
开盘$17.95
昨收$17.69
当日区间$17.51 – $18.50
成交量1.06M
市值$2.63B
市盈率（TTM）–
股息率–
RCUS 相关新闻
匹配 Arcus Biosciences 或代码 RCUS 的头条新闻，按最新排序。
- Truist Financial Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Announces Target Price $40
- Wedbush Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $43
- LifeSci Capital Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $46
- H.C. Wainwright Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $45
- Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences (RCUS), Prime Medicine, Inc. (PRME) 正面
- TD Cowen Initiates Arcus Biosciences(RCUS.US) With Buy Rating
- Citi Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $45
- Goldman Sachs Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Raises Target Price to $42 正面
- A Quick Look at Today's Ratings for Arcus Biosciences(RCUS.US), With a Forecast Between $42 to $45
- BofA Securities Maintains Arcus Biosciences(RCUS.US) With Hold Rating, Raises Target Price to $29 正面
- Goldman Sachs Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $42
- Wedbush Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $41
- Truist Financial Maintains Arcus Biosciences(RCUS.US) With Buy Rating
- H.C. Wainwright Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Raises Target Price to $45 正面
- LifeSci Capital Initiates Arcus Biosciences(RCUS.US) With Buy Rating, Announces Target Price $46
暂无评论——快来第一个聊聊 RCUS。
登录后参与讨论。